Literature DB >> 1569374

Changes in the size of reconstituted high density lipoproteins during incubation with cholesteryl ester transfer protein: the role of apolipoproteins.

K A Rye1, K H Garrety, P J Barter.   

Abstract

It has been reported previously that the particle size distribution of discoidal, reconstituted HDL (r-HDL) changes dramatically during incubation in vitro with cholesteryl ester transfer protein (CETP). The present study was undertaken in order to determine whether these changes are influenced by the apolipoprotein composition of the r-HDL. Two preparations of r-HDL that contained egg phosphatidylcholine (egg PC) and unesterified cholesterol (UC) but differed in their apolipoprotein composition were used for the study. One preparation contained apolipoprotein (apo) A-I only (A-I w/o A-II r-HDL) while the other contained apoA-I and apoA-II (A-I w A-II r-HDL). The Stokes' radius of the major population of particles in the (A-I w/o A-II) and (A-I w A-II) r-HDL was, respectively, 4.8 and 4.9 nm. When the (A-I w/o A-II) r-HDL were incubated with CETP, most of the particles of radius 4.8 nm were converted to populations of smaller and larger particles. The smaller particles had Stokes' radii of 4.3 and 3.9 nm. The radii of the larger particles ranged from 8.2 to 13.7 nm. When the (A-I w A-II) r-HDL were incubated with CETP larger particles (Stokes' radii = 8.4-11.0 nm) appeared but there was minimal conversion to smaller particles. In addition, a significant proportion of the original (A-I w A-II) r-HDL of radius 4.9 nm was still present at the end of the incubation. These results are consistent with apoA-II inhibiting the conversion of r-HDL to small particles. It is concluded that the apolipoprotein content of r-HDL is an important determinant of the sizes of the particles that are formed during incubation with CETP.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1569374

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  7 in total

1.  Formation of apolipoprotein-specific high-density lipoprotein particles from lipid-free apolipoproteins A-I and A-II.

Authors:  M A Clay; D A Cehic; D H Pyle; K A Rye; P J Barter
Journal:  Biochem J       Date:  1999-02-01       Impact factor: 3.857

2.  Dramatically decreased high density lipoprotein cholesterol, increased remnant clearance, and insulin hypersensitivity in apolipoprotein A-II knockout mice suggest a complex role for apolipoprotein A-II in atherosclerosis susceptibility.

Authors:  W Weng; J L Breslow
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

3.  Double superhelix model of high density lipoprotein.

Authors:  Zhiping Wu; Valentin Gogonea; Xavier Lee; Matthew A Wagner; Xin-Min Li; Ying Huang; Arundhati Undurti; Roland P May; Michael Haertlein; Martine Moulin; Irina Gutsche; Giuseppe Zaccai; Joseph A DiDonato; Stanley L Hazen
Journal:  J Biol Chem       Date:  2009-10-07       Impact factor: 5.157

4.  Human ApoA-II inhibits the hydrolysis of HDL triglyceride and the decrease of HDL size induced by hypertriglyceridemia and cholesteryl ester transfer protein in transgenic mice.

Authors:  S Zhong; I J Goldberg; C Bruce; E Rubin; J L Breslow; A Tall
Journal:  J Clin Invest       Date:  1994-12       Impact factor: 14.808

5.  Identification of Critical Paraoxonase 1 Residues Involved in High Density Lipoprotein Interaction.

Authors:  Xiaodong Gu; Ying Huang; Bruce S Levison; Gary Gerstenecker; Anthony J DiDonato; Leah B Hazen; Joonsue Lee; Valentin Gogonea; Joseph A DiDonato; Stanley L Hazen
Journal:  J Biol Chem       Date:  2015-11-13       Impact factor: 5.157

6.  Modification of high density lipoprotein by myeloperoxidase generates a pro-inflammatory particle.

Authors:  Arundhati Undurti; Ying Huang; Joseph A Lupica; Jonathan D Smith; Joseph A DiDonato; Stanley L Hazen
Journal:  J Biol Chem       Date:  2009-09-02       Impact factor: 5.157

7.  Insulin promotes macrophage foam cell formation: potential implications in diabetes-related atherosclerosis.

Authors:  Young M Park; Sangeeta R Kashyap; Jennifer A Major; Roy L Silverstein
Journal:  Lab Invest       Date:  2012-04-23       Impact factor: 5.662

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.